Abortion-related morbidity in six Latin American and Caribbean countries: findings of the WHO/HRP multi-country survey on abortion (MCS-A).


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
08 2021
Historique:
received: 05 03 2021
accepted: 10 06 2021
entrez: 21 8 2021
pubmed: 22 8 2021
medline: 13 10 2021
Statut: ppublish

Résumé

Abortion-related complications are a significant cause of morbidity and mortality among women in many Latin American and Caribbean (LAC) countries. The objective of this study was to characterise abortion-related complication severity, describe the management of these complications and report women's experiences with abortion care in selected countries of the Americas region. This is a cross-sectional study of 70 health facilities across six countries in the region. We collected data on women's characteristics including socio-demographics, obstetric history, clinical information, management procedures and using Audio Computer-Assisted Self-Interviewing (ACASI) survey the experience of abortion care. Descriptive bivariate analysis was performed for women's characteristics, management of complications and reported experiences of abortion care by severity of complications, organised in five hierarchical mutually exclusive categories based on indicators present at assessment. Generalised linear estimation models were used to assess the association between women's characteristics and severity of complications. We collected data on 7983 women with abortion-related complications. Complications were classified as mild (46.3%), moderate (49.5%), potentially life-threatening (3.1%), near-miss cases (1.1%) and deaths (0.2%). Being single, having a gestational age of ≥13 weeks and having expelled products of conception before arrival at the facility were significantly associated with experiencing severe maternal outcomes compared with mild complications.Management of abortion-related complications included both uterotonics and uterine evacuation for two-thirds of the women while one-third received uterine evacuation only. Surgical uterine evacuation was performed in 93.2% (7437/7983) of women, being vacuum aspiration the most common one (5007/7437, 67.4%).Of the 327 women who completed the ACASI survey, 16.5% reported having an induced abortion, 12.5% of the women stated that they were not given explanations regarding their care nor were able to ask questions during their examination and treatment with percentages increasing with the severity of morbidity. This is one of the first studies using a standardised methodology to measure severity of abortion-related complications and women's experiences with abortion care in LAC. Results aim to inform policies and programmes addressing sexual and reproductive rights and health in the region.

Identifiants

pubmed: 34417270
pii: bmjgh-2021-005618
doi: 10.1136/bmjgh-2021-005618
pmc: PMC8404437
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Bull World Health Organ. 2014 Mar 1;92(3):155
pubmed: 24700971
Lancet. 2006 Nov 25;368(9550):1887-92
pubmed: 17126721
BMJ Sex Reprod Health. 2018 May 7;:
pubmed: 29972364
BJOG. 2016 Aug;123(9):1489-98
pubmed: 26287503
Cad Saude Publica. 2020 Apr 6;36Suppl 1(Suppl 1):e00168419
pubmed: 32267402
Int J Gynaecol Obstet. 2012 Sep;118 Suppl 1:S21-7
pubmed: 22840266
Glob Health Action. 2020 Dec 31;13(1):1811482
pubmed: 32867629
J Epidemiol Community Health. 2003 Aug;57(8):601-5
pubmed: 12883066
Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):287-96
pubmed: 19303368
Int J Gynaecol Obstet. 2010 Aug;110(2):175-80
pubmed: 20605151
PLoS One. 2018 Feb 7;13(2):e0192547
pubmed: 29414987
Stud Fam Plann. 2003 Jun;34(2):87-102
pubmed: 12889341
BMC Int Health Hum Rights. 2018 Sep 12;18(1):35
pubmed: 30208877
Reprod Health. 2014 Sep 24;11:72
pubmed: 25249396
Int J Gynaecol Obstet. 2012 Jul;118(1):83-6
pubmed: 22608022
Best Pract Res Clin Obstet Gynaecol. 2020 Jan;62:11-24
pubmed: 31230835
Reprod Health. 2016 Nov 4;13(1):134
pubmed: 27814759
Lancet. 2017 Nov 25;390(10110):2372-2381
pubmed: 28964589
Int J Gynaecol Obstet. 2012 Sep;118 Suppl 1:S15-20
pubmed: 22840265
Int J Gynaecol Obstet. 2020 Aug;150(2):200-205
pubmed: 32304228
Reprod Health. 2012 Dec 22;9(1):34
pubmed: 23259660
BMJ Glob Health. 2018 Jun 29;3(3):e000692
pubmed: 29989078
Sex Reprod Health Matters. 2021 Dec;29(1):1890868
pubmed: 33734025
Syst Rev. 2017 Aug 3;6(1):152
pubmed: 28768550
Glob Ment Health (Camb). 2016 Aug 12;3:e24
pubmed: 28596892
Int J Gynaecol Obstet. 2015 Dec;131(3):285-8
pubmed: 26460669
PLoS One. 2016 Mar 24;11(3):e0152224
pubmed: 27010629
BJOG. 2005 Sep;112(9):1291-6
pubmed: 16101610
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33514590
BMJ Glob Health. 2016 Nov 25;1(3):e000113
pubmed: 28588967
Int J Gynaecol Obstet. 2018 Jul;142(1):120-124
pubmed: 29656526
Public Health. 1998 May;112(3):157-63
pubmed: 9629022
Int J Gynaecol Obstet. 2010 Jul;110 Suppl:S20-4
pubmed: 20451200
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833

Auteurs

Mariana Romero (M)

Health, Economy and Society Department, CEDES, Buenos Aires, Argentina mromero@cedes.org.
CONICET, Buenos Aires, Argentina.

Rodolfo Gomez Ponce de Leon (R)

Latin American Center for Perinatology/Women's Health and Reproductive Health, Pan American Health Organization (CLAP/WR-PAHO/WHO), Montevideo, Uruguay.

Luiz Francisco Baccaro (LF)

UNICAMP, Campinas, Brazil.

Berenise Carroli (B)

CREP, Rosario, Santa Fe, Argentina.

Hedieh Mehrtash (H)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Jimena Randolino (J)

CREP, Rosario, Santa Fe, Argentina.

Elisa Menjivar (E)

Pan American Health Organization El Salvador, San Salvador, El Salvador.

Erika Estevez Saint-Hilaire (E)

Hospital Materno Infantil San Lorenzo de los Mina, Santo Domingo, Dominican Republic.

Maria Del Pilar Huatuco (MDP)

ESSALUD, Lima, Peru.

Rosalinda Hernandez Muñoz (R)

Pan American Health Organization Bolivia, La Paz, Bolivia, Plurinational State of.

Gabriela Garcia Camacho (G)

CREP, Rosario, Santa Fe, Argentina.

Soe Soe Thwin (SS)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Liana Campodonico (L)

CREP, Rosario, Santa Fe, Argentina.

Edgardo Abalos (E)

CREP, Rosario, Santa Fe, Argentina.

Daniel Giordano (D)

CREP, Rosario, Santa Fe, Argentina.

Hugo Gamerro (H)

CREP, Rosario, Santa Fe, Argentina.

Caron Rahn Kim (CR)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Bela Ganatra (B)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Metin Gülmezoglu (M)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Özge Tuncalp (Ö)

UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, WHO, Geneva, Switzerland.

Guillermo Carroli (G)

CREP, Rosario, Santa Fe, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH